Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection
Clinical trial NCT02058108 · TERMINATED
Trial details
- NCT number
- NCT02058108
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-31
- Primary completion
- 2019-01-09
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.